Sanders Bager

Infectious complications diminished from 25% to 16.4% (-6.1, 95%CI -11.5 to-0.7), reoperations from 8.1% to 6.1% (-2.2, 95%CI -5.1 to+0.6), median length of stay from 11 [IQR 8-18] to 8 [7-12] days (p<0.001), hospital readmission from 14.1% to 8.9% (-5.4, 95%CI -9.6 to-1.1), mortality from 7.9% to 4.8% (-2.4, 95%CI -4.7 to-0.01), and failure-to…[Read more]

The transcription factor Nrf2 is a central regulator of anti-inflammatory and antioxidant mechanisms that contribute to the development and progression of various neurological disorders. Although the direct and indirect Nrf2 regulatory roles on inflammation have been reviewed in recent years, the in vivo evidence of Nrf2 function on…[Read more]